@article{acac3b8bc6724fc0ad8563dbb586c73e,
title = "Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial",
keywords = "PATIENT-REPORTED OUTCOMES, ANKYLOSING-SPONDYLITIS, MONOCLONAL-ANTIBODY, CERTOLIZUMAB PEGOL, DOUBLE-BLIND, CRITERIA, ETANERCEPT, EFFICACY",
author = "J.A. Walsh and M.N. Magrey and X. Baraliakos and K. Inui and M.Y. Weng and E. Lubrano and {van der Heijde}, D. and A. Boonen and L.S. Gensler and V. Strand and J. Braun and T. Hunter and X.Q. Li and B.J. Zhu and L. Leon and D.M.S. Calderon and U. Kiltz",
year = "2022",
month = mar,
doi = "10.1002/acr.24482",
language = "English",
volume = "74",
pages = "451--460",
journal = "Arthritis Care and Research",
issn = "2151-4658",
publisher = "Wiley",
number = "3",
}